A group of doctors is urging a U.S. court to block the Food and Drug Administration (FDA) from issuing guidance on using ivermectin, in an appeal lodged after a district court judge rejected their bid.
The FDA “cannot advise whether or for what purpose a doctor should prescribe, or a patient should take, an approved drug,” lawyers for Drs. Paul Marik, Mary Talley Bowden, and Robert Apter said in a February brief to the U.S. Court of Appeals for the Fifth Circuit.